Skip to main content

Effect of combination of multiple anti-inflammatory drugs strategy on postoperative delirium among older patients undergoing hip fracture surgery: a pilot randomized controlled trial.

BMC medicine2025-02-22PubMed
Total: 84.0Innovation: 8Impact: 8Rigor: 9Citation: 8

Summary

In a dual-center, double-blind pilot RCT (n=132 randomized; 123 analyzed), a perioperative anti-inflammatory bundle (dexmedetomidine, glucocorticoid, ulinastatin, NSAIDs) reduced postoperative delirium from 44% to 15% (RR 0.33; P=0.001) without major adverse events. Lower postoperative CRP partially mediated the effect, supporting inflammation as a causal pathway.

Key Findings

  • Postoperative delirium was reduced from 44% (27/61) to 15% (9/62) with the anti-inflammatory bundle (RR 0.33; 95% CI 0.17–0.64; P=0.001).
  • No major adverse events occurred in either group, supporting safety of the bundled approach.
  • Postoperative CRP levels were significantly lower with the bundle, and mediation analysis implicated systemic inflammation in the protective effect.

Clinical Implications

If replicated, anesthesiologists could adopt protocolized anti-inflammatory bundles to prevent delirium in high-risk geriatric fracture surgery, integrating dexmedetomidine sedation, a single perioperative steroid dose, ulinastatin, and NSAIDs with careful patient selection and monitoring.

Why It Matters

This rigorously blinded pilot RCT demonstrates a substantial reduction in postoperative delirium using a pragmatic, multi-target anti-inflammatory strategy, a leading cause of morbidity in older surgical patients.

Limitations

  • Pilot sample size and two-center setting limit generalizability
  • Bundle design precludes disentangling the contribution of individual drugs; short (3-day) delirium follow-up

Future Directions

Conduct adequately powered, multicenter RCTs to confirm efficacy, optimize dosing/timing, assess long-term cognitive and functional outcomes, and evaluate cost-effectiveness and safety in broader populations.

Study Information

Study Type
RCT
Research Domain
Prevention
Evidence Level
I - Randomized, double-blind, placebo-controlled trial provides highest-level clinical evidence.
Study Design
OTHER